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BACKGROUND 
●The presentation and marketing is critical for 
initial engagement of parents with OUDs 
●Methods require future training for EI providers 
on recovery 
●Beginning parenting programs prior to the birth 
of the child may encourage parent enrollment 
●Peer sharing (recovery coach) involvement in 
some capacity may also be beneficial to parents 
UMMS-Baystate Research:  Together we advance the state of caring through discovery & innovation 
METHODS 
To explore barriers and facilitators to integrating a 
targeted parenting intervention for families 
affected by OUDs into child home-visiting services 
Barriers and Facilitators of Incorporating a New Program for Parents in 
Recovery into Early Intervention Services 
Briana Jurkowski1,2; Carolina Clark, MSW, LCSW1; Michael Moran1; Elizabeth Peacock-Chambers, MD, MS1 





●13 parents and 25 providers 
●Provider occupations included EI providers, an 
EI director, a DPH program coordinator, 
hospital staff, DCF, social workers, recovery 
program staff, and mental health providers 
●Focus groups took place in Greenfield, 
Northampton, and Springfield, MA 
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●Infants born to parents with opioid use 
disorders (OUDs) are at higher risk for 
developmental delays and future educational 
and behavioral problems 
●These infants frequently qualify for Early 
Intervention (EI) child development services 
●EI is a possible source of support at a critical 
time for parents with OUDs 
●There are few targeted approaches to 
supporting families in recovery through child 
home-visiting services 
●Inclusion criteria: Parents in recovery from 
OUDs with children under 10 years of age in 
Western Massachusetts and providers of 
addiction child development health or social 
services 
●Semi-structured qualitative interviews and focus 
groups were conducted (N=38) 
●Each interview or focus group was transcribed, 
coded, and analyzed using a qualitative 
descriptive approach 
RESULTS ADDITIONAL RESULTS 
Collaborative Care for Kids: A Resident Driven School Nurse Education Initiative 
Kelsey Kaman MD¹ and Jhill Shah DO¹, Taylor Koerner MD¹, Chandrika Sridharamurthy MD¹   
¹University of Massachusetts Medical School-Baystate 
BACKGROUND: OBJECTIVE: DESIGN: 
RESULTS: 
CONCLUSIONS: 
• In 2018 Springfield was named the worst city in the 
county to live with asthma  
 
• We met with community stakeholders and realized 
that collaborating with school nurses would be a 
great way to help alleviate the burden of asthma in 
the pediatric population 
 
• During initial meetings, school nurses made us aware 
that there are many other conditions that they would 
like more guidance on managing and overcoming  
barriers to care 
 
• According to the AAP in “Role of the School Nurse in 
Providing School Health Services”,  school nurses are 
critical in management of ADHD, diabetes, life-
threatening allergies, asthma, seizures and behavioral 
health concerns 
 
• We also recognized that when school nurses are not 
confident in their skills, they are more likely to send 
children perhaps inappropriately home or to 
Emergency Departments resulting in lost time at 
school for the kids and lost time at work for the 
parents. By addressing this issue, we hope to be 
helping every school aged child in Springfield to 
optimize their health and educational opportunities  
 
• Our aim: Residents to teach 5 courses throughout the 
year about recognizing and caring for common 
complaints and urgent situations that could arise in 




• 5 classes over the course of one  academic school 
year held during regularly scheduled professional 
development classes 
 
• Address 5 areas: Asthma, Allergies, Skin Rashes, 
Neuro: Seizures and Concussions, and Abdominal 
Complains  
 
• Pre-test and post-test at each session 
 
• Incentives for participation include coffee 
breakfast s, gift cards, and end of the year raffles 
Figure 1: Pre and Post-Testing scores for Asthma Class  
For asthma session, the average pre-test score was 66.1%. 
The post-test scored an average of 74.5%. 
• Our first session was asthma and was a very successful event 
that every school nurse in Springfield attended 
 
• We learned about common misconceptions school nurses have 
about asthma and were able to address many of them  
 
• Importantly, we also learned things we as community 
pediatricians can do to help nurses manage asthma better in the 
outpatient setting such as yearly asthma action plans, labels for 
inhalers, encouraging kids with asthma (and their families) to 
continue to walk to school, play outside during recess and 
participate in gym 
 
• Enhance nursing medical knowledge of 
common pediatric complaints and 
management in the school setting  
 
• Foster open, easy, reliable, and efficient 
communication between school nurses 
and local  pediatricians 
 
• Link school nurses with community 
resources  including non-profit 
organizations as well as local pediatricians 











Figure 2: On a scale from 1-5, how comfortable are you 














New Nurse Pre-test New Nurses Post-
test
Figure 1: Pre-test and Post-test Results 
Multifactorial Renal Injury in a Pancreatic Cancer Patient 
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LEARNING OBJECTIVES 
1. Review mechanisms for renal injury in cancer patients  
2. Evaluate a unique case of IgA nephropathy and explore the 
possible pathophysiologic mechanisms  
     
● This patient’s underlying pancreatic cancer and chemotherapy 
likely caused IgA nephropathy.  
 
● IgA nephropathy is thought to be a result of genetic and 
environmental factors in a "multi-hit" model of renal injury.1  
 
● IgA nephropathy may be primary or secondary. Secondary IgA 
nephropathy can be caused by a variety of systemic illnesses 
including neoplastic disorders and is thought to be due to 
increased IgA production, production of abnormal IgA or 
impaired clearance.  
 
● There have been case reports of association with malignancy 
and chemotherapy that posit mucosal injury secondary to 
metastatic disease itself, chemotherapies, radiation and surgery 
lead to glomerular IgA immune complex deposition.  
 
● Other confounders in this case include acute tubular injury 
secondary to contrast induced ATN from a CT scan done as part 
of her workup, possibly augmented by dehydration from the 
side effects of chemotherapy.       
     
    
   
   ● Nephrotoxicity is a common complication of treatment in 
patients with malignancy, however may be underestimated due 
to subclinical presentation or lack of standardized 
surveillance.2   
● This is illustrated in this case as the patient’s renal injury was 
unexpected and likely multifactorial. 
● Initially there was concern for thrombotic microangiopathy, a 
well known complication of gemcitabine therapy, given her 
rapidly rising creatinine and precipitously falling platelets.3  
Biopsy did not show TMA, however did reveal acute tubular 
injury (ATN) and IgA nephropathy.  
CASE PRESENTATION  
DISCUSSION 
DISCUSSION CONTINUED 
A 66 y/o female with a past medical history significant for 
pancreatic cancer on gemcitabine and paclitaxel presented to the 
ED with fever, nausea, vomiting, and tachycardia in the setting of 
recent initiation of chemotherapy. She was initially started on 
broad spectrum antibiotics for possible sepsis however these 
were discontinued as it became more apparent that her 
presenting symptoms were likely side effects of chemotherapy. 
On hospital day #5 patient’s course become complicated by 
marked increase in creatinine from 0.8mg/dL to 3.2 mg/dL and 
worsening thrombocytopenia. Her creatinine peaked at 4.6 mg/dL. 
An ultrasound guided needle kidney biopsy was performed. 
Biopsy results were significant for acute tubular injury with likely 
underlying IgA nephropathy. Patient’s creatinine nomalized with 
IV fluids. 
      




      
 
CONCLUSION 
Malignancy and chemotherapy can both cause renal injury such 
as IgA nephropathy. Thus, it is important to remain vigilant about 
monitoring for potential effects of malignancy and antineoplastic 
drugs. Increased monitoring of renal function may be indicated in 
patients with malignancy in order to better understand and 
prevent renal injury.  
      
     
    
   
   
HOSPITAL DAY # CREATININE (mg/dL) PLATELETS  
k/mm3 
4 0.8 80 
5 2.9 72 
5 (recheck)  3.2 72 
6 4.2 66 
7 4.6 67 
8 4.6 79 
9 4.4 95 
10 4.3 95 
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Figure 1: Renal Biopsy. Glomerular tuft with hypercellularity 
cons is tent with IGAN and confirmed by light microscopy4 
 
Figure 2: Patient’s lab data. Illus trates  patient’s  s teep rise in 
creatinine with falling platelet count and the s tart of 
subsequent recovery  
